Investor Intelligence: Rapid Reactions

Time-sensitive analysis of major developments as they unfold.

Weekly Wrapup: Beyond the headlines of the week ended April 19, 2019

As another week in cannabis ends, another industry-record deal has investors and observers wondering what’s next. Here’s a recap of the top newsmakers and deals that kept us busy here at Investor Intelligence – plus a look at what we’ll be watching for next week: Canopy Growth’s Big U.S. Bet The bold $3.4 billion bet […]

Read More

Rapid Reaction: Top takeaways from Canopy’s $3.4 billion deal to buy Acreage

You’ve no doubt heard the big buzz by now: Canadian cannabis giant Canopy Growth struck a $3.4 billion deal to buy New York-based Acreage Holdings. The move would be the first major Canada-U.S. cannabis deal – but the purchase won’t be executed until the American government removes federal marijuana prohibition. Here are key takeaways Investor […]

Read More

Weekly Wrapup: Beyond the headlines of the week ended April 12, 2019

M&A activity is spiking, Pennsylvania lawmakers are mixing things up for one big marijuana player, and Trulieve rocked its Q4 earnings. Those headlines and more grabbed our attention here at Investor Intelligence this week. Here’s a recap of the week’s top newsmakers and deals – plus a look at what we’ll be watching for next […]

Read More

Rapid Reaction: Can Trulieve Translate Its Winning Model to Markets Outside Florida?

Florida-based Trulieve Cannabis Corp. (CSE: TRUL; OTC: TCNNF) solidified its position as the most profitable U.S. public marijuana company with its fourth-quarter and full-year earnings results, filed after the markets closed Wednesday. Here are the top takeaways: Earnings Highlights Trulieve reported fourth-quarter revenue of $35.9 million, up from $28.3 million in the same quarter last […]

Read More

Weekly Wrapup: Beyond the headlines of the week ended April 5, 2019

It’s been another monumental week in cannabis with massive multimillion-dollar deals, big news out of Florida and the launch of a new cannabis-focused fund. Here’s a recap of the top newsmakers and deals that caught our eyes here at Investor Intelligence – plus a look at what we’ll be watching for next week: Cresco Labs […]

Read More

Rapid Reaction: Does Cresco’s acquisition of Origin House help make it a CPG target?

Cresco Labs CEO Charlie Bachtell told Investor Intelligence last month that the company’s growth strategy would be focused on a combination of organic and transactional activity. Today’s news that the Chicago-based multistate cannabis operator (MSO) will acquire Canada’s Origin House – a major player in brands and distribution – in a deal worth roughly $823 million […]

Read More

Weekly Wrapup: Beyond the headlines of the week ended March 29, 2019

We’re wrapping up another busy week as earnings season ramps up and key cannabis banking legislation moves forward in the United States. Here’s a recap of the top newsmakers and moments that caught our eye here at Investor Intelligence this week, plus a look at what we’re watching next week: CannTrust eyes U.S. hemp market […]

Read More

Rapid Reaction: Analysts, Investors Remain in the Dark on Cronos’ Recreational Sales

Toronto-based licensed cannabis company Cronos Group (Nasdaq: CRON) had sizable revenue growth in 2018 but still missed the mark for analysts. The company’s net loss also increased sharply – the company reported a profit the prior year – fueled in large part by a change in financial reporting requirements, the company said in its earnings report. […]

Read More

Weekly Wrapup: Beyond the headlines of the week ended March 22, 2019

It’s been another action-packed week in cannabis with new public listings, big earnings news and more signals that institutional investors are stepping off the sidelines and dipping their toes into legal marijuana markets. Here are the top newsmakers and deals that caught our eyes here at Investor Intelligence – plus a look at what we’ll […]

Read More

Rapid Reaction: Curaleaf-CVS deal an ‘insitutional stamp of approval’

Massachusetts-based Curaleaf on Wednesday reported that its fourth-quarter sales more than quadrupled compared to the same quarter a year ago and unveiled news that it has inked a deal with the CVS pharmacy chain to begin selling hemp products at 800 stores in 10 states. Curaleaf Hemp lotions and transdermal patch products will start hitting […]

Read More

Rapid Reaction: What’s Behind Acreage Holdings’ $218 Million Loss?

New York-based Acreage Holdings’ fourth-quarter net loss widened sharply compared to the year before, but analysts say that should not be cause for great concern as the company spent heavily on expanding its footprint in 2018. Revenue for the firm nearly quadrupled last year. The company, which trades on the Canadian Securities Exchange under the ticker symbol ACRG.U, […]

Read More